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Abstract

The purpose of this research was to develop a deletion construct for the
chemoautotrophic bacterium Halothiobacillus neapolitanus, which will be used to generate
a mutant lacking a carboxysome shell protein gene. The carboxysome is the location of
carbon dioxide fixation. The operon that encodes the carboxysome contains three genes for
CsoS1 proteins, the major components of the carboxysome shell. The small CsoS1 proteins
self-assemble into hexamers with small central pores. The hexamers arrange into the facets
of the icosahedral carboxysome shell. The pores are believed to be involved in selective
diffusion of materials necessary for carbon dioxide fixation across the shell.
A deletion construct to replace the csoS1C gene with a kanamycin resistance
cassette was designed that will allow gene replacement by homologous recombination to
determine if the csoS1C paralog is necessary to form functional carboxysomes. This
deletion construct will allow the function of this paralog to be studied in the resulting
mutant. To develop the construct, primers were designed to amplify the kanamycin
resistance gene with short ends that are homologous to regions flanking the csoS1C gene
in the H. neapolitanus genome. E. coli DY330 was transformed with the amplified
resistance cassette and a plasmid containing the csoS1C region of genomic DNA for
homologous recombination that will yield the deletion construct.

Keywords: carboxysome, carbon dioxide fixation, homologous recombination, paralog,
csoS1C, kanamycin resistance cassette
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Chapter I: Introduction
Bacterial microcompartments (BMCs) are small, polyhedral protein structures
found in bacteria.1,2 These structures are protein shells that encase enzymatic reactions,
sequestering the reactants and products from the rest of the cell, increasing enzymatic
activity, and/or protecting the cell from potentially harmful by-products.3 The genes that
code for the shell protein components of BMCs are highly conserved among the BMC
containing bacteria.2 There are three types of conserved BMC shell proteins: hexamers,
pentamers, and tandem domains.4 BMCs are interesting to study because they have the
capability to self-assemble, which has potential applications in synthetic biology.5 The
BMC of interest to this research is the carboxysome (Figure 1).
All cyanobacteria and many chemoautotrophs contain carboxysomes.3,5 In nature,

Figure 1. Structure of the Carboxysome. Also showing assembly of hexameric
proteins. (Heinhorst, S.; Cannon, G.; Nat. Struct. Mol. Biol. 2008. 15. 898-898)
there exist two types of carboxysomes, distinguishable by different protein compositions,
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the α-carboxysome and the β-carboxysome.1 The model organism for the study of αcarboxysomes is Halothiobacillus neapolitanus, which is a chemoautotroph that utilizes
CO2 and inorganic sulfur compounds as a carbon and energy source, respectively.3 The
predominant enzyme housed in the carboxysome is ribulose 1,5-bisphosphate
carboxylase/oxygenase (RuBisCO). RuBisCO is the enzyme that fixes inorganic carbon
dioxide in the first step of the Calvin-Bensen-Bassham cycle.1–3 The proposed higher
concentration of CO2 inside the carboxysome allows the enzyme to function effectively in
low CO2 environments.
The carboxysome shell protein genes are located in the cso operon. Within the cso
operon are three homologous genes—csoS1C, A, B—that code for the nearly identical
major shell proteins. While it is known that the carboxysome shell is primarily composed
of the CsoS1 proteins, it is not yet known if all three paralogs are required for the structure
or function of the carboxysome shell.6 The goal of this research was to develop a deletion
construct that will allow for the study of the role of the csoS1C gene and CsoS1C protein
in the structure and function of the carboxysome.
Chapter II: Literature Review
Bacterial microcompartments (BMCs) are the bacterial equivalents of eukaryotic
organelles.1,2,6 Eukaryotic organelles have specific purposes inside the cell, as do the
BMCs. BMCs are polyhedral protein structures with an approximately 100 nm diameter,
that contain various enzymatic reactions.1,2 Containing the reactions benefits the cell by
increasing enzyme activity, sequestering dangerous intermediates, and/or shielding the
enzyme reaction from inhibitors.3 The genes that code the three BMC protein components
are conserved in roughly a fourth of all bacterial genomes.2 Additionally, the ability of
2

BMCs to self-assemble makes them candidates for synthetic biology research.5 Research
into the various components of BMCs may allow for the development of synthetic, selfassembling, molecular structures that could be designed to sequester commercially
valuable enzymatic reactions.7 Alternatively, existing BMCs could be genetically
engineered to sequester new and different enzymes of interest.8
The carboxysome is the most studied BMC and the only BMC involved in anabolic
metabolism.3,5 This BMC is found in all cyanobacteria and many chemoautotrophs,
including the model organism Halothiobacillus neapolitanus.3,5 Halothiobacillus
neapolitanus is a chemoautotroph that oxidizes inorganic sulfur compounds to obtain
energy.3 Halothiobacillus neapolitanus lives in a relatively low CO2 environment and
requires a CO2-concentrating mechanism (CCM) in which the carboxysome plays a vital
role.1
The carboxysome encases ribulose 1,5-bisphosphate carboxylase/oxygenase
(RuBisCO), which is the CO2-fixing enzyme of the Calvin-Bensen-Bassham (CBB)
cycle.1–3 RuBisCO catalyzes the attachment of CO2 to ribulose-1,5-bisphosphate and the
following cleavage of the six carbon intermediate into two 3-phosphoglycerate (3-carbon)

Figure 2. Carbon Fixation Within the Carboxysome. Cytosolic HCO3- is converted
to CO2 by carbonic anhydrase inside the carboxysome. RuBisCO then fixes CO2 onto
ribulose-1,5-bisphosphate (RubP), which yields two molecules of 3-phosphoglycerate (3PGA). Image courtesy of Dr. Sabine Heinhorst.
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molecules.9 As inorganic carbon is transported into the cell, it is equilibrated to mostly
bicarbonate, which cannot be used by RuBisCO; however, the charged bicarbonate cannot
cross the lipid membrane to exit the cell. The cytosolic concentration of bicarbonate
steadily increases and becomes higher than the concentration of bicarbonate inside the
carboxysome, creating a concentration gradient across the protein shell (Figure 2). The
concentration gradient helps to facilitate diffusion of bicarbonate across the carboxysome
shell. It is thought that carbonic anhydrase associated with the protein shell accelerates the
equilibration between the HCO3- and CO2 as HCO3- diffuses across the protein shell into
the carboxysome.1 It is also believed that some feature of the carboxysome shell prevents
the CO2 from diffusing back out of the carboxysome (Figure 3).10,11
The carboxysome contains the final step in the CCM. The concentrated levels of
inorganic carbon (bicarbonate) in the cytosol result in high levels of CO2 inside the
carboxysome (Figure 2). The carbonic anhydrase creates a saturated CO2 environment

Figure 3. Molecular Transport Through the CsoS1 Hexamer Pores in
the Carboxysome Shell. Image source: Yeates, et al. 2008.
4

Figure 4. Genes of the cso Operon. Also shown are the structures of the
carboxysome and of the CsoS1 shell protein hexamers. Image courtesy of Dr.
Sabine Heinhorst.
within the carboxysome, allowing the RuBisCO to function with greater efficiency and
enhanced catalytic activity.1 Without the CCM and sequestered RuBisCO the bacterium is
unable to grow efficiently in environments with low CO2 concentrations, such as air.10
All bacteria with the potential to develop BMCs have similar hexamer-forming
BMC protein components, and genes that tend to be present as multiple paralogs.4 The
major α-carboxysome shell proteins are the CsoS1 proteins. The genes for the CsoS1
proteins are contained in the cso operon (Figure 4). Within the cso operon are three csoS1
paralogs that code for the predominant shell proteins; however, the csoS1D gene is located
outside of the operon. The three csoS1 genes within the operon code for nearly identical
proteins. The CsoS1C and CsoS1A proteins are different by only two amino acids and
CsoS1B has an additional twelve amino acids on the C-terminus.5,12,13 The CsoS1 proteins
are small monomers that are assembled into hexamers (Figure 5). The CsoS1D protein is
a pseudo-hexamer that may form a highly selective pore, but still requires more research
regarding its function.14
5

The CsoS1 proteins assemble into hexamers with six-fold symmetry. The hexamers
have two different sides, one of which is hydrophobic and concave.15 Hexamer assembly
results in the formation of small central pores, which may allow for the selective diffusion
of reactants and products of the RuBisCO reaction across the protein shell (Figures 2 and
5).13 The assembly of the hexamers forms the facets of the icosahedral carboxysome shell.

Figure 5. Assembly of CsoS1 Monomers. (Yeates, et al. 2011)

6

Hydrogen bonding between the hexamers assists the packing of the hexamers into the
facets.15
It is not yet known if the three CsoS1 proteins are functionally redundant or if they
each serve a different purpose in the carboxysome shell. It is hypothesized that each csoS1
gene codes for a monomer that yields a hexamer with a pore of slightly different
permeability.5,13 For example, it has been proposed that the carboxysome shell prevents the

Figure 6. Structure of CsoS1C Hexamer. Six CsoS1C monomers assemble
into the hexamer, forming the central pore. Image source:
http://www.rcsb.org/pdb/explore/explore.do?structureId=3H8Y
competitive inhibitor O2 from reaching RuBisCO.2 It is necessary to study the three
homologues separately to determine their biological significance by knocking out their
genes and studying the resulting carboxysomes.
The long-term purpose of this research is to study the function of the csoS1C gene
and consequently the CsoS1C protein (Figure 6) in Halothiobacillus neapolitanus
carboxysomes. By replacing the csoS1C gene with a kanamycin resistance cassette, a

7

mutant can be generated in which the function of the protein encoded by the deleted gene
is missing. The ability of Halothiobacillus neapolitanus to grow in air is determined by the
ability of the carboxysome to function in the CO2 concentrating mechanism.13 If the mutant
carboxysomes are not fully functional, the bacterium should be unable to effectively
concentrate and fix CO2 at ambient CO2 concentrations. Such an outcome would suggest
that the CsoS1C protein is vital for a functional carboxysome shell. However, if the mutant
carboxysomes are unaffected, the CsoS1C protein may not be essential to the formation
and/or function of the shell.
Chapter III: Materials and Methods
Materials and Bacterial Strains
Media
Luria-Bertani Broth (LB Broth)
10 g/L NaCl
10 g/L Bacto tryptone
5 g/L Bacto yeast extract
Luria-Bertani Agar (LBA)
15 g/L Agar
10 g/L Bacto tryptone
10 g/L NaCl
5 g/L Bacto yeast extract
S.O.C. Medium (Invitrogen)
20 g/L Bacto tryptone
5 g/L Bacto yeast extract
20 mM Glucose
10 mM NaCl
10 mM MgCl2
10 mM MgSO4
2.5 mM KCl
Dyes
Ethidium Bromide 1% (10 mg/mL)
Fisher BioReagents
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6X Gel Loading Dye Blue
New England Biolabs
1X Buffer Components (pH 8.0 at 25℃)
2.5% Ficoll®-400
11 mM EDTA
3.3 mM Tris-HCl
0.017% SDS
0.015% bromophenol blue
Buffers
TBE Buffer (pH 8.0)
108 g/L Tris-Base (pH 7.8)
55 g/L Boric Acid
40 mL 0.5M EDTA (pH 8.0)
10X TE Buffer (pH 8.0)
100 mM Tris-HCl (pH 8.0)
10 mM EDTA (pH 8.0)
Antibiotic Solutions
Aqueous ampicillin (100 μg/mL) and kanamycin (50 μg/mL) were used at 100 mg/mL
and 50 mg/mL final concentrations, respectively.
PCR Master Mixes and DNA Ladders
10X ThermoPol Reaction Buffer (pH 8.8 at 25℃)
New England Biolabs
200 mM Tris-HCl
100 mM (NH4)2SO4
100 mM KCl
20 mM MgSO4
0.1% Triton® X-100
Deoxynucleotide (dNTP) Solution Mix (pH 7.3)
Thermo Scientific™
Aqueous solution of each dNTP at 10 mM
2X GoTaq® Green Master Mix (pH 8.5)
Promega
GoTaq® DNA Polymerase
400 μM dATP
400 μM dGTP
400 μM dCTP
400 μM dTTP
3 mM MgCl2
9

1 kb DNA Ladder (pH 8.0 at 25℃)
New England Biolabs
DNA fragments of 500 bp to 10,002 bp size range
10 mM Tris-HCl
1 mM EDTA
100 bp DNA Ladder (pH 8.0 at 25℃)
New England Biolabs
DNA fragments of 100 bp to 1,517 bp size range
10 mM Tris-HCl
1 mM EDTA
Plasmids and E. coli Strains
One Shot®TOP10 chemically competent E. coli cells (Invitrogen) for transformation of
plasmids
pCR®-Blunt II-TOPO® vector (Invitrogen) for cloning, sequencing and generating
glycerol stocks of amplified DNA
pUC18 plasmid DNA (Thermo Scientific) for generation of deletion constructs
E. coli DY330 for electroporation and homologous recombination
Water
Deionized (DI) water from the house line was purified using a Barnstead™ Nanopure
Diamond Lab Water Purification System, a Barnstead™ RO System (Thermo Scientific).
Methods
Gel Electrophoresis
To separate and visualize DNA fragments a 0.7% agarose gel was prepared in 1X
TBE. Ethidium bromide (40 μg/μL per gel) was added to the still liquid agarose solution
to visualize the DNA. The gel was loaded with an appropriate DNA ladder and subjected
to 100 V until the bands of loading dye (NEB) migrated the desired distance across the gel.
The gel was imaged under UV light (VersaDoc Imaging System, Bio-Rad).
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Overnight Bacterial Cultures for Plasmid DNA Purification
A liquid and solid culture of bacteria containing the target plasmid was prepared
for plasmid purification using sterile technique. Liquid cultures were prepared in 5 mL
Falcon™ Round-Bottom Polystyrene Tubes (Fisher Scientific). Each culture contained 5
mL of LB medium and 5 μL of ampicillin and/or kanamycin solution to select for the
desired plasmid. Cells from either glycerol stocks or transformed TOP10 E. coli cells were
used to inoculate the cultures. The liquid cultures of TOP10 E. coli cells were incubated at
37℃ and cultures of E. coli DY330 cells were incubated at 30℃ with agitation overnight.
The solid cultures were prepared on LB agar plates containing ampicillin and/or
kanamycin. The plates with TOP10 E. coli cells were incubated at 37℃ overnight, and the
plates with E. coli DY330 cells were incubated at 30℃ overnight.

Plasmid Purification Protocol
To isolate the plasmids from the liquid cultures, the cultures were first centrifuged
at 9,000 rpm for 10 minutes (JA 25.5 rotor) to pellet the cells; the supernatant was removed
from the cell pellet and discarded. Plasmid DNA was then isolated from the pelleted cells
using a Fermentas GeneJET Plasmid Miniprep Kit (Thermo Scientific). The pelleted cells
were resuspended using 250 μL of the provided Resuspension Solution. The cell
suspension was transferred to a 1.5 mL microcentrifuge tube. Next, 250 μL of the included
Lysis Solution was added and the cell solution was mixed by inverting the tube. After
mixing, 350 μL of the Neutralization Solution was added and the solution quickly mixed
by inverting. The solution was centrifuged for 5 minutes at 14,000 rpm. The supernatant
11

was transferred to the supplied GeneJET™ spin column and centrifuged for 1 minute. The
flow-through was discarded. The column was washed with 500 μL of the Wash Solution
and centrifuged for 1 minute; this wash step was repeated twice. The empty column was
centrifuged an additional minute. The DNA was eluted with 50 μL of deionized (DI) water
and incubated at room temperature for 2 minutes before being centrifuged for 2 minutes.
The eluate was collected in a fresh microcentrifuge tube.
Determination of DNA Concentration
The concentration of purified plasmid DNA was found using a NanoDrop® ND1000 Spectrophotometer. The concentration was reported in ng/μL.
Screening for Recombinants/ Colony Lysis PCR
Screening transformants for recombinants included streaking single colonies on
LBA plates containing an appropriate antibiotic and colony lysis PCR.
To screen for positive transformants, eight single colonies were selected and
streaked on an antibiotic containing LBA plate (Figure 7). Transformants of pUC18
constructs required ampicillin, TOPO vector constructs required kanamycin, and pUC18
constructs with KanR inserted required both antibiotics on separate plates. The plates were
incubated overnight at 37℃ for TOP10 E. coli and 30℃ for E. coli DY330.
After streaking the LBA plates (Figure 7), the inoculating loop was swirled in 25
μL of TE to use for colony lysis PCR. The suspended cells were lysed by boiling at 100℃
for 1 minute. The DNA from the lysed cells was substituted as the DNA template for the
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Figure 7. Streaking Pattern for Recombinant Screening.
TOPO-Kan plasmids were screened using the PCR program listed in Table 1 and
the Master Mix in Table 6. The primers designed for the KanR cassette were used for
amplification.
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Table 1. PCR parameters for Colony PCR of TOPO-Kan Transformants (program
name: edkan1)

Temperature

Time

Cycles

95℃

3 minutes

1

95℃

30 seconds

50℃

30 seconds

72℃

1 minute

72℃

10 minute

1

12℃

∞

Hold

30

Recombinant pUC18 constructs were screened using the GoTaq® Green Master
Mix (Table 5) and CBStandard PCR program listed in Table 2. The M13-20F and M1326R (Eurofins) primers were used for these amplifications.
Table 2. Reaction Parameters of CBStandard PCR Program

Temperature

Time

Cycles

95℃

3 minutes

1

95℃

30 seconds

55℃

30 seconds

72℃

1 minute

72℃

5 minutes

1

12℃

∞

Hold

30

Restriction Digest
Restriction enzymes were used to linearize circular DNA into fragments of
identifiable size. These fragments were used to generate new constructs and to test for the
14

presence of specific fragments in generated constructs. The restriction digest reaction
(Table 3) contained a specific restriction enzyme(s) that cut the DNA at the desired
location. A buffer (NEB) was chosen according to the enzyme used. The reaction was
incubated at an appropriate temperature for 1 hour. The restriction products were separated
and visualized by gel electrophoresis.
Table 3. General Reaction for Restriction Digestions

Reagent

Amount

NEB 10X Buffer

2.5 μL

DNA Template

1 μg (500 ng)

Restriction Enzyme

1 μL

DI water

Up to 24 μL

Final Volume

24 μL

DNA Recovery by Gel Extraction
Once the DNA fragments were separated on the agarose gel, the desired fragment
was excised from the gel. The fragment was extracted from the gel using the QIAEX II®
Gel Extraction Kit from Qiagen. The mass of gel excised was determined, and Buffer QXI
(included in kit) was added using 3 volumes of buffer for fragments 100 bp-4 kb. The
QIAEX II reagent (included in kit) was resuspended by vortexing for 30 s, and 10 μL were
added to the gel. The reaction was incubated at 50℃ for 10 min, vortexing every 2 min to
help dissolve the gel and allow the DNA to bind to the QIAEX II reagent. Next the reaction
was centrifuged at 13,000 rpm for 30-60 s and the supernatant discarded. The pellet was
washed with 500 μL of Buffer QXI and resuspended by vortexing. The solution was
centrifuged again for 30-60 s and the supernatant discarded. The pellet was then washed
twice with 500 μL Buffer PE by resuspending the pellet, centrifuging for 30-60 s, and
15

discarding the supernatant. The pellet was then allowed to air dry until white. The pellet
was resuspended in 20 μL of water and allowed to incubate at room temperature for 5 min
then centrifuged for 30-60 s. The supernatant containing the isolated DNA was removed
and saved. The concentration of DNA extracted was determined by UV absorbance.
Preparation of the KanR Cassette
Primer Design
In order to amplify the KanR cassette and replace the csoS1C gene, primers (Figure
14) were designed with sequence homology to both the sequence surrounding the
Halothiobacillus neapolitanus csoS1C gene and the KanR cassette. Working stock primers

Figure 8. Amplification of KanR Cassette. The black lines represent DNA
containing the kanamycin resistance gene. The black arrows are the portion of the
designed primers that anneal to the kanamycin resistance gene, and the red lines are
the base pairs that anneal to the regions flanking csoS1C in the Halothiobacillus
neapolitanus genome. Source:
http://www.sci.sdsu.edu/~smaloy/MicrobialGenetics/topics/in-vitro-genetics/redswap.html
were created by diluting 5 μL of stock primer with 45 μL DI H2O.

Amplification of KanR cassette via Polymerase Chain Reaction
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The Polymerase Chain Reaction (PCR) was used to amplify the KanR cassette with
ends homologous to sequences up- and downstream of csoS1C using the previously
designed primers. Amplified KanR PCR products were used for transformation of E. coli
DY330 cells, and for insertion into the pCR®-Blunt II-TOPO® vector for sequencing and
glycerol stocks. PCR reactions were performed using a Bio-Rad MyCycler™ thermal
cycler. The program used for amplification of the KanR cassette was 95℃ for 3 min; 5
cycles of 95℃ for 30 s, 49℃ for 30 s, and 72℃ for 1 min; 25 cycles of 95℃ for 30 s, 62.9
℃ for 30 s, and 72℃ for 1 min; 72℃ for 5 min, and a hold temperature of 12℃ (Table 2).
Five microliters of the PCR products were used for visualization via gel electrophoresis.
Table 4. Reaction Parameters for Amplification of KanR (program name: edkansh)

Temperature Time
95℃

3 minutes

95℃

30 seconds

49℃

30 seconds

72℃

1 minute

95℃

30 seconds

62.9℃

30 seconds

72℃

1 minutes

72℃

5 minutes

12℃

∞

Cycles
1

5

25

1
Hold

The KanR cassette prepared for transformation of E. coli DY330 used the GoTaq®
Green Master Mix provided by Promega. The reaction mixture is listed in Table 5.
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Table 5. GoTaq® PCR Reaction Master Mix

Reagent

Volume

Concentration

GoTaq® Green Master Mix, 2X

12.5 μL

1X

Forward Primer

1 μL

0.5 μM

Reverse Primer

1 μL

0.5 μM

9.5 μL

N/A

1 μL

50 ng

Water
KanR Template
Total

25 μL per reaction

The E. coli DY330 cells were transformed using amplified KanR from the PCR
reaction listed in Table 2, and with purified PCR products as a control. The products of an
identical PCR reaction were purified using the GeneJET™ PCR Purification Kit and
included protocol from Fermentas.
The KanR cassette amplified for insertion into the pCR®-Blunt II-TOPO® vector
for sequencing and glycerol stocks used the “Routine Deep Vent PCR” Master Mix
outlined by NEB and listed in Table 6.
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Table 6. Master Mix Reagents for Deep Vent PCR

Reagents

Volume Concentration

ThermoPol Reaction Buffer (10X)

2.5 μL

0.5X

Deoxynucleotide (dNTP) Solution Mix (10 mM) 2.0 μL

200 μM

Forward Primer

1.0 μL

0.5 μM

Reverse Primer

1.0 μL

0.5 μM

Deep Vent (Taq) Polymerase

0.5 μL

1U

Water

17 μL

N/A

Total (per reaction)

24 μL

The reaction parameters are listed in Table 4.
TOPO® Cloning Reaction/Transforming One Shot® Competent Cells
The KanR PCR product was inserted into the pCR®-Blunt II-TOPO® vector
(Figure 9) for sequencing and generation of glycerol stocks (700 μL liquid culture and 300
μL 80% glycerol) for long term storage. The KanR PCR product was cloned using the Zero
Blunt® TOPO® PCR Cloning Kit supplied by Invitrogen™.
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Figure 9. pCR®-Blunt II-TOPO® Vector Map. From
http://tools.thermofisher.com/content/sfs/vectors/pcrbluntiitopo_map.pdf
Next, One Shot®TOP10 chemically competent E. coli cells (Invitrogen) were
transformed with the plasmid DNA. A vial of cells were thawed on ice before adding 2 μL
of the TOPO® cloning reaction. The cells were incubated on ice for 30 minutes. The cells
were then heat-shocked for exactly 30 seconds at 42℃ without shaking, and immediately
transferred back to ice. Next, 250 μL of room temperature S.O.C medium were added. The
cells were agitated (200 rpm) at 37℃ horizontally for 1 hour. While the reaction was
incubating, two LB plates containing kanamycin were warmed to room temperature. After
incubation, 50 μL of the reaction were plated on one plate, and 200 μL on the other. These
plates were incubated at 37℃ overnight. Positive recombinants were selected and screened
using colony lysis PCR (Table 1).
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Sequencing
Positive transformants were selected for plasmid purification and subsequent
sequencing. The purified recombinant TOPO plasmids were sent to Eurofins Genomics for
sequencing—the company outlined the reaction specifications (150 ng DNA in water for a
total of 15 μL). The sequencing results were used to determine if the KanR PCR product
contained the Halothiobacillus neapolitanus flanking sequence.
Preparation of pUC18-HnPE2.0 Vector Plasmid
The pUC18-HnPE2.0 construct was previously created in the Shively lab. The
glycerol stocks were used to inoculate overnight cultures that were used for plasmid
purification.

Figure 10. Plasmid Map of pUC18-HnPE2.0. Fragment PstI-EcoRI is
1,962 bp and fragment EcoRI-PstI is 2,656 bp.
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Generation of pUC18-HnPE2.0csoS1C Plasmid
An additional plasmid was generated that contains 372 bp upstream of csoS1C
and 431 bp downstream of the gene. The plasmid was generated by excising an 873 bp
fragment from the pUC18-HnPE2.0 plasmid by digestion with ApoI, and re-ligating the
plasmid. ApoI only cuts within the H. neapolitanus region of the pUC18-HnPE2.0
plasmid (Figure 10).

Figure 11. Vector Map of pUC18HnPE2.0csoS1C. Fragment PstI-XmnI is 1,002
bp. Fragment XmnI-XmnI is 1,940 bp, and fragment XmnI-PstI is 808 bp.
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Digestion of pUC18-HnPE2.0 with ApoI
The restriction digest is listed in Table 7. The reaction was incubated at 50℃ for
1 hour and stopped by the addition of 5 μL of gel loading dye. The 3750 bp fragment was
excised from the agarose gel using the QIAEX II® Gel Extraction Kit; however, an
additional centrifugation step was added to each spin cycle to completely remove the
supernatant. Additionally, two 10 μL elution steps were used to increase the yield in the
eluate.
Table 7. Restriction Digest Reaction for ApoI

Reagent

Amount

pUC18HnPE2.0 #1 339.3 ED 11.5.15

2.95 μL (1000.9 ng)

NEB Buffer 3.1 (or 3.0)

2.5 μL

ApoI

1.0 μL

Water to 20 μL

13.55 μL

Ligation of ApoI Digested Plasmid
The plasmid digested with ApoI was ligated back to itself using the T4 DNA
Ligase provided by NEB. The reaction used followed the general protocol suggested for
use with the T4 DNA Ligase (Table 8). The reaction was mixed gently by pipetting
followed by a brief centrifugation. The reaction was incubated overnight at 16℃ and the
ligase inactivated by freezing.
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Table 8. Ligation Reaction using T4 DNA Ligase from NEB

Reagent
Amount
10XT4 DNA Ligase Buffer 2 μL
Plasmid DNA

50 ng

Water

To 20 μL

T4 DNA Ligase

1 μL

Transformation of TOP10 cells
The same protocol listed under TOPO® Cloning Reaction/Transforming One
Shot® Competent Cells was used to transform a tube of TOP10 E. coli cells with 2 μL of
chilled ligation product. The transformed cells were plated on LBA plates containing
ampicillin. Eight colonies from the transformation step were screened (Figure 7). Four
positive transformants were selected for glycerol stocks and plasmid purification. The
pUC18-HnPE2.0csoS1C plasmid with the highest concentration was selected to continue
to DY330.
Transformation of DY330
Preparation of competent DY330 cells
Overnight cultures of DY330 were prepared and incubated at 30°C. The liquid
culture was used to inoculate two 50 mL subcultures in baffled flasks. The subcultures
were incubated at 30°C (225 rpm) until the OD600 reached 0.5. One of the 50 mL
subcultures was divided into two 25 mL subcultures. The 50 mL and one 25 mL subculture
was incubated at 42°C and the other 25 mL subculture was incubated at 30℃ creating the
uninduced control. All cultures were then transferred to an ice/water slurry and cooled
while shaking for 15 minutes. The cells were transferred to Falcon tubes and harvested by
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centrifuging (JA 25.5 rotor) at 4 ℃ for 10 minutes 4,000 rpm. The supernatant was
discarded and the cells were resuspended in 1 mL of ice-cold DI water. The cell suspension
was transferred to microcentrifuge tubes and centrifuged at 14,000 rpm and 4℃ for 20
seconds. The supernatant was discarded and the pellet washed with 1 mL ice-cold DI water.
The centrifugation and wash step was repeated a total of three times. The final pellet was
resuspended in 200 μL ice-cold water and kept on ice until electroporation.
Electroporation of DY330 cells
Equimolar amounts of the linear donor DNA (KanR amplification product) and
plasmid acceptor DNA (pUC18-HnPE2.0 or pUC18-HnPE2.0csoS1C at approximately
0.14 pmol) were added to a pre-cooled electroporation cuvette along with 100 μL of
competent DY330 cells. The cells were electroporated at 2.0 kV, 25 μF with the pulse
controller set to 200 Ohms. Immediately after electroporation, 1 mL of LB was added to
the cuvette and the reaction was transferred to a Falcon tube. The electroporated cells were
incubated on ice for 5 minutes, then shaken at 30°C for 1.5 h. The cells were plated in 200
μL aliquots on LBA plates containing kanamycin and ampicillin and incubated at 30°C
overnight. A total of six different reactions were conducted using both pUC18HnPE2.0csoS1C and pUC18-HnPE2.0 and both purified and unpurified KanR PCR
products and two control reactions. One control reaction used cells from the uninduced
culture. The other control introduced the pUC18-HnPE2.0 plasmid to DY330 to insure that
the electroporation step did not kill the cells. This reaction was plated on a LBA plate
containing only ampicillin.

25

Table 9. Reactions used for the Electroporation of DY330

Reaction Number Vector Plasmid
pUC18-HnPE2.0csoS1C
Reaction 1

Linear Donor
Purified KanR PCR Product

Reaction 2

pUC1-HnPE2.0csoS1C

Unpurified KanR PCR Product

Reaction 3

pUC18-HnPE2.0

Purified KanR PCR Product

Reaction 4

pUC18-HnPE2.0

Unpurified KanR PCR Product

Reaction 5

pUC18-HnPE2.0

Unpurified KanR PCR Product

Reaction 6

pUC18-HnPE2.0

N/A

Colonies from the overnight plates of electroporated cells were selected for colony
PCR using GoTaq® Green Master Mix (Table 5) and standard M13 primers. The PCR
program was CBStandard (Table 2) using 23 μL of master mix and 2 μL of template
(lysate). The screened colonies were also streaked on LBA plates containing kanamycin
(Figure 7). The colony PCR products were visualized using gel electrophoresis.
Isolation of Deletion Construct
Colonies from Reaction 2 and Reaction 4 were selected and grown on kanamycin
plates at 30℃ overnight. Colonies from these cultures were prepared for colony PCR as
described in the preceding section. To obtain single plasmid colonies, 4 colonies from
Reaction 2 and Reaction 4 were selected on LBA plates containing kanamycin.
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Figure 12. Predicted Deletion Construct of pUC18HnPE2.0csoS1C
Recombination. Fragment PstI-XmnI is 1,638 bp; fragment XmnI-XmnI is 1,940 bp, and
fragment XmnI-PstI is 808 bp.
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Figure 13. Predicted Deletion Construct of pUC18HnPE2.0 Recombination.
Fragment PstI-EcoRI is 2,598 bp and fragment EcoRI-PstI is 2,656 bp.
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Colonies from these cultures were again selected and prepared for colony PCR
(Table 2). Liquid LB cultures containing kanamycin and ampicillin were inoculated with
2 colonies from each reaction. The cultures were incubated overnight at 30 ℃ with
agitation. The plasmids from these cultures were isolated (see Plasmid Purification
Protocol).
To further study the results of the recombination, the isolated plasmids were
digested to identify characteristic fragments. Each restriction digestion contained 500 ng
of plasmid DNA. The plasmids from Reaction 2 were digested with PstI and XmnI (NEB),
in a reaction containing NEBuffer 2.1. The plasmids from Reaction 4 were digested with
PstI and EcoRI (NEB) in a reaction containing NEBuffer 3.1.
The plasmid from Reaction 2 clone 7 was diluted to 210 pg/μL and used to
transform TOP10 E. coli cells. The transformants were plated on a LBA plate containing
kanamycin, one containing ampicillin, and one without an antibiotic for control. Cultures,
both liquid LB and a LBA plate with kanamycin, were inoculated with 6 transformant
colonies and incubated overnight at 37℃. Glycerol stocks were prepared from the liquid
cultures. The plasmids were isolated (see Plasmid Purification Protocol), and subsequently
digested as described previously. Two plasmids were sequenced.
Chapter IV: Results
Preparation of the KanR Cassette
The primers designed to amplify the KanR cassette with ends homologous to the
flanking regions of csoS1C were designed. The preferred length of the region of homology
is 45 nucleotides up- and downstream of the csoS1C gene, to allow for efficient
homologous recombination in E. coli DY330. The primers should not self-anneal or anneal
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to each other; additionally, both primers needed to denature around the same temperature
for amplification. The Oligo Analyzer program on the Integrated DNA Technologies (IDT)
site was used to analyze potential primer designs (http://www.idtdna.com/site). The
resulting primers used for the amplification of the kanamycin resistance cassette are shown
in Figure 14. The forward primer added 47 bp of H. neapolitanus DNA, and the reverse
primer added 44 bp to the end of the KanR cassette (Figure 15).

Forward Primer (62 bp) Tm=74.5℃
5’-cgctagatgagttgattttgaatgagtctttattgaggagagaagaaCCGGAATTGCCAGCTG-3’
Reverse Primer (65 bp), Tm=78.7℃
5’-aaagaaccggaacaagcctgcgccggttcgtctttcccaatcctCAGAAGAACTCGTCAAGAAGG-3’
Figure 14. Primer Design for Amplification of KanR Cassette with Regions of
Homology Flanking the H. neapolitanus csoS1C gene. Lowercase sequence designates
sequence from Halothiobacillus neapolitanus. Uppercase sequence designates sequence
that anneals to the kanamycin resistance gene.
In order to confirm the sequence and generate glycerol stocks of the KanR cassette,
the amplified PCR product was cloned into the pCR®-Blunt II-TOPO vector.
The recombinant construct was
transformed

into

One

Shot®

TOP10 competent E. coli cells for
selection of positive recombinants.
Plasmids from positive clones
(Figure 16) were isolated and used
for sequence confirmation and for
KanR

Figure 15. Amplification of
Cassette.
R
Lane Kan contains product cloned into pCR®-Blunt the generation of glycerol stocks.
II-TOPO Vector. Water was used as negative control
(no DNA template; lane C). Lane L100 contains the The sequencing confirmed the
100 bp ladder.
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presence of the KanR cassette with ends homologous to H. neapolitanus DNA. The PCR
products obtained were confirmed to be the KanR cassette, and the PCR primers and

Figure 16. Colony Lysis PCR of TOPO-Kan Clones. The expected fragment was
1,023 bp. The negative control used water instead of template DNA. L100 is 100 bp DNA
ladder, 1-8 are the screened clones, C is the control.
protocols were used subsequently.
The linear KanR cassette used for the electroporation of DY330 was obtained by
amplification by PCR using the GoTaq® master mix and a TOPO-Kan cassette as the DNA
template. The two sets of PCR products were obtained. One set was purified to remove
residual PCR reagents and loading dye and the other was not. The purified PCR product
had a concentration of approximately 24 ng/μL, and the concentration of the unpurified

Figure 17. KanR Cassettes Used as Donor DNA for Homologous Recombination.
Left: PCR product used unpurified. Right: PCR product before purification. L1kb is 1 kb
DNA ladder, KanR is PCR product, Control or C is the water control.
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PCR product was estimated to be 25 ng/μL by comparison to the concentration of the NEB
ladder fragments.
Preparation of pUC18-HnPE2.0 Vector Plasmid
The pUC18-HnPE2.0 plasmid was isolated from glycerol stocks of TOP10 cells
containing the plasmid. The purified plasmid used for consecutive steps had a final
concentration of approximately 340 ng/μL.
Generation of pUC18-HnPE2.0csoS1C Plasmid
To develop the pUC18-HnPE2.0csoS1C plasmid, the pUC18-HnPE2.0 plasmid
was digested with the restriction enzyme ApoI. The digestion was expected to yield two
fragments, one 873 bp and the other 3,750 bp. The 873 bp fragment corresponds to the
region of DNA to be removed from the pUC18-HnPE2.0 insert, and the 3,750 bp

Figure 18. Digestion of pUC18HnPE2.0 with ApoI. The desired fragment indicated
at 3,750 bp was excised from the gel. L1kb contains the 1 kb DNA ladder, ApoI Fragments
are the resulting fragments from digestion.
corresponds to the remaining fragment. Both fragments were visualized in the expected
region on the gel (Figure 18). The desired fragment at 3,750 bp was excised from the gel.
The resulting concentration of the fragment was 26 ng/μL. The excised fragment
underwent self-ligation to yield the new plasmid construct. The ligation products were used
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to transform TOP10 E. coli cells. Eight colonies were randomly selected for screening with
colony lysis PCR. The amplified fragment was expected to be approximately 1,099 bp,
which was seen on the gel (Figure 19). Four of the positive colonies were used to generate

Figure 19. Colony PCR of pUC18HnPE2.0csoS1C. Clones selected for the
generation of glycerol stocks are indicated with a square, the clone used as acceptor DNA
was clone 3. The negative control used water instead of template DNA. L1kb is 1kb DNA
ladder, 1-3 are screened colonies, C is water control.
glycerol stocks. The pUC18-HnPE2.0csoS1C used for the electroporation of DY330 had a
final concentration of 361 ng/μL.
Transformation of DY330
The E. coli DY330 cells were co-transformed with an acceptor plasmid and the
linear KanR cassettes generated through PCR amplification (see Table 9 for reactions). All
transformants were able to grow on LBA plates containing ampicillin and kanamycin.
However, colony lysis PCR of the first generation clones revealed double fragments,
indicative of mixed plasmids, and fragments of incorrect size (Figure 20). Recombinants
of the pUC18HnPE2.0 plasmid were expected to yield a fragment of approximately 2,700
bp and recombinants of pUC18HnPE2.0csoS1C were expected to yield a fragment of
approximately 1,800 bp after colony lysis PCR amplification. However, amplification of
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Figure 20. Colony PCR of First Generation DY330 Clones. The control labeled C1
amplified pUC18HnPE2.0csoS1C and the C2 control amplified pUC18HnPE2.0. L1kb is
1kb DNA ladder, 1-4 are screened colonies, C are the controls.
Reactions 1 and 2 resulted in fragments approximately 1,000 bp and 600 bp, and Reactions
3 and 4 showed fragments approximately 1,200 bp and 1,900 bp long.
In an attempt to separate the plasmids, colonies from Reaction 4 (pUC18-HnPE2.0
= acceptor plasmid) and colonies from Reaction 2 (pUC18-HnPE2.0csoS1C = acceptor
plasmid) were further isolated by selection on kanamycin plates. These second generation
clones were able to grow in the presence of kanamycin; however, the colony lysis PCR
again resulted in double bands (Figure 21). Amplification of Reaction 2 resulted in a
fragment approximately 1,000 bp long and amplification of Reaction 4 resulted in
fragments approximately 1,200 bp and 1,900 bp.
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Figure 21. Second Generation Colony PCR Results. Clones from Reaction 4.1 and
4.2 were selected from different LBA plates. Reaction 4 control was pUC18HnPE2.0, and
Reaction 2 control was pUC18HnPE2.0csoS1C. Colonies selected to continue are
indicated by a square. L1kb is 1kb DNA ladder, 1-8 are screened colonies, C is control.
Four colonies from each reaction were selected and grown on kanamycin plates in
an attempt to isolate the recombinant plasmid. Figure 22 shows the results of the colony
lysis PCR. Amplification of the third generation clones still resulted in double fragments,

Figure 22. Colony PCR on Third Generation Clones. The control for Reaction 4
was pUC18HnPE2.0, and the control for Reaction 2 was pUC18HnPE2.0csoS1C. L1kb is
1kb DNA ladder, 1.1 is clone 1 from Reaction 4 plate 1, 1.3 was clone 3 from Reaction 4
plate 1, 2.1 is clone 1 from Reaction 4 plate 2, 2.2 is clone 2 from Reaction 4 plate 2. 1 is
clone 1 from Reaction 2, 2 is clone 2 from Reaction 2, 4 is clone 4 from Reaction 2, 7 is
clone 7 from Reaction 2. C indicates controls.
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and fragments that were of similar sizes to the original plasmids (Figure 22). Reaction 4
had two bands of approximately 1,200 bp and 1,900 bp. Reaction 2 exhibited fragments of
approximately 1,000 bp and 800 bp.

Identification of Recombination Events
Since the colony PCR results were inconclusive, a different method was used to
determine the results of the recombination. Plasmids were isolated from Reaction 2
numbers 1 and 7, Reaction 4 number 1.1, and Reaction 4 number 2.2 (Figure 22). Plasmids
from Reaction 2 were digested with PstI and XmnI, and plasmids from Reaction 4 were

Figure 23. Restriction Digest of Plasmids from Reactions 2 and 4. Digestion of
plasmid 2.1 contained an error, 2.7 shows a pattern indicative of mixed original and
recombinant plasmids. Digestion of plasmids 4.1 and 4.2 did not result in expected
fragments. L1kb is 1kb DNA ladder. pUC18-HnPE2.0csoS1C and pUC18-HnPE2.0 were
used as controls.
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digested with PstI and EcoRI. The resulting fragment pattern (Figure 23) was used to
identify which plasmids were present in the cells (Figure 23).
Different fragments were expected from the digestion of the recombinant plasmid
and the original plasmid (Figures 13 and 14). Digestion of pUC18HnPE2.0csos1C
plasmid with PstI and XmnI produced three fragments approximately 1.9 kb, 1.0 kb, and
0.8 kb, which can be seen in Figure 23. Digestion of pUC18HnPE2.0 with PstI and EcoRI
results in two fragments approximately 2.6 kb and 1.9 kb (Figure 23). The recombinant
pUC18HnPE2.0csoS1C should show fragments approximately 1.6 kb, 1.9 kb, and 0.8 kb.
The fragments from the digested pUC18HnPE2.0 recombinant should be approximately
2.7 kb and 2.6 kb. As shown in Figure 23, the plasmids isolated from the E. coli DY330
cells appeared to be a mixture of original and recombinant plasmids. To isolate the
recombinant plasmid, TOP10 E. coli cells were transformed with 210 pg of the purified
plasmid DNA isolated from one of the transformants (Reaction 2 number 7, Figure 22).
From the transformants that were able to grow in the presence of kanamycin, plasmid DNA
was isolated from selected colonies and digested with PstI and XmnI (Figure 24). It
appears that separation of the original and recombinant plasmids was obtained. As seen in
Figure 24, lanes 2 and 5 contained a fragment of approximately 4.3 kb, which corresponds
to the length of the linearized recombinant plasmid. In lanes 1, 3, and 6 the 4.3 kb fragment
is not present; however, the fragments characteristic of the original acceptor plasmid DNA
are present. Since the two fragment patterns are not present in the same lane, and thus the
same bacterial colony, the original and recombinant plasmids have been separated. Possible
linearization of the recombinant occurred as well. The presence of a single fragment at
approximately 4.3 kb instead of the predicted three fragments suggests that the recombinant
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Figure 24. Restriction Digest of Diluted Plasmids. Plasmids digested were isolated
from TOP10 E. coli transformed with diluted 2.7 plasmids. Clone #5 and #6 were used for
sequencing. L1kb is 1kb DNA ladder. #1-6 are screened colonies, C is digested pUC18HnPE2.0csoS1C.
plasmid was simply linearized rather than completely digested. To examine the
recombination site, plasmid DNA from two colonies was sequenced.
The plasmid DNA from clones 5 and 6 (Figure 24) was sequenced. The sequencing
results from the M13 forward primer of plasmid 5 did not show any homology to the
expected recombinant sequence. The sequencing results using the M13 reverse primer for
plasmid 5 exhibited alignment with the kanamycin resistance gene. The forward
sequencing reaction of plasmid 6 indicated homology with the expected recombinant
sequence upstream of the predicted insertion site of the kanamycin cassette and
downstream of the cassette, but no homology with the predicted cassette site. A BLAST
alignment using the original csoS1 region as the query revealed that csoS1C had not been
replaced by the kanamycin cassette. However, the reverse reaction showed alignment with
the kanamycin cassette. The sequencing results of both plasmids suggest that the
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kanamycin cassette was inserted in the acceptor plasmid, but did not replace the csoS1C
gene.
Chapter V: Discussion and Conclusion
The KanR cassette was generated to replace the csoS1C gene in the cso operon
(Figure 4). The KanR cassette was amplified with approximately 45 base pairs of H.
neapolitanus DNA on each end to allow for efficient sequence recognition by the lambda
recombinase that is overexpressed in E. coli DY330. A shorter sequence would have
resulted in less efficient recombination.16 The amplification of the KanR cassette was
successful as indicated by the sequencing results. A purified PCR product and an
unpurified PCR product were used as linear donor DNA for the transformation of E. coli
DY330. Transformations with both PCR products resulted in colonies able to grow on the
LBA plates containing kanamycin and ampicillin after electroporation. The transformants
from purified PCR reactions resulted in more, smaller colonies after plating, while the
transformants from unpurified PCR reactions grew fewer, larger colonies. A higher colony
count suggests that the purified PCR products had a higher rate of transformation and
recombination. The size difference in the colonies may simply be the result of resource
competition. More colonies on a plate mean less nutrients for each colony, thus restricting
the size of the colony. Since both reactions resulted in colonies, both were screened for
recombinants.
The pUC18-HnPE2.0csoS1C plasmid used as the acceptor DNA was designed to
include approximately 500 base pairs of DNA up- and downstream of the csoS1C gene to
increase the success rate of recombination. The number of csoS1 paralogs (2 paralogs) in
this plasmid is lower than in the original pUC18-HnPE2.0 plasmid (3 paralogs). The
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pUC18-HnPE2.0 plasmid contains csoS1C, A, B, and csoS4A/B while the new plasmid
lacks the csoS1B gene that may interfere with correct insertion of the kanamycin cassette
into csoS1C. The purpose of the pUC18-HnPE2.0csoS1C plasmid was to obtain a circular
acceptor containing the csoS1C gene with approximately a 500 bp buffer region on each
end. The resulting fragment contains 372 bp upstream of the gene and 431 bp downstream
of the gene. Since intermolecular ligation is more favorable than intramolecular ligation, a
restriction enzyme was selected that cut the original plasmid in two locations only in the
csoS1 region of the plasmid. The restriction enzyme ApoI was the only enzyme that cut
only twice and in the desired location on the insert. The digest and subsequent gel
extraction removed 873 bp from the csoS1 region (Figure 18). The new plasmid was used
along with the original plasmid as the circular receptor DNA for homologous
recombination.
Both plasmids were used for electroporation of DY330, and both plasmids resulted
in colonies. Colonies from both plasmids and both PCR products were screened for
recombinants. Successful homologous recombination should have resulted in a single band
at approximately 1,800 bp fragment after colony PCR from the pUC18-HnPE2.0csoS1C
plasmid and a 2,670 bp fragment from the pUC18-HnPE2.0 plasmid. Additionally, if
homologous recombination had not occurred the bacteria should not have been able to grow
on LBA plates containing kanamycin.
The colony lysis PCR showed double bands, and bands similar in size to the original
plasmids. Although the expected fragments were not seen, the bacteria were able to grow
on kanamycin plates indicating a recombination event had taken place. The double
fragments suggest that both original acceptor plasmid DNA and recombinant plasmid DNA
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were present in the cells. To determine if the kanamycin cassette had been incorporated
into the genome of DY330 instead of the acceptor plasmids, the plasmids were purified
and used to transform TOP10 E. coli. The transformants were able to grow on kanamycin
plates, which confirms that the recombination event did occur in the acceptor plasmids.
A restriction digest of the plasmids was conducted to examine the location of the
recombination event(s). The resulting fragmenting patterns of the plasmids in Figure 23
(Reaction 4) were inconclusive. The resulting fragments either matched the original
plasmid, or were smaller than any predicted fragment from either original or the expected
recombined plasmids. The remaining fragments in Figure 23 (Reaction 2) were as
expected for a mixture of both original and recombinant plasmids. Fragments
corresponding to linearized original plasmid (3.7 kb) and recombinant plasmid (4.3 kb)
were seen, as well as fragments expected from the digestion of the original
pUC18HnPE2.0csoS1C plasmid. In a mixture of both plasmids, a double band was
expected approximately at 1.9 kb. Both plasmids were expected to show a fragment at 1.9
kb, and the recombinant was expected to have a fragment at 1.6 kb. The only fragment that
was not expected from the digestion of Reaction 2 was the fragment approximately 3.0 kb.
It is possible that this fragment was the result of partial digestion of a plasmid.
In order to isolate the recombinant plasmid, the purified plasmids were diluted
before being used to transform TOP10 E. coli cells to increase the likely hood of each cell
taking up only a single plasmid. Cells transformed with the recombinant plasmid were able
to grow on LBA plates containing kanamycin. Plasmids were isolated from six of the
positive colonies, and digested with PstI and XmnI. Of the six, two digestions did not show
fragments corresponding to the original plasmid; the other four digestions did not show a
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band corresponding to linearized recombinant plasmid DNA. All six reactions lacked a
fragment at 1.9 kb. Both enzymes were functional since control digestion of the original
acceptor plasmid DNA yielded the expected digestion pattern. Plasmid DNA from
transformants resulting in each digestion pattern (Figure 24, clones 5 and 6) was sequenced
to determine the outcome(s) of the recombination.
The sequencing results obtained from the extension of the M13 reverse primer of
the linearized single band plasmid (Figure 24, clone 5), showed sequence similarity to the
kanamycin resistance gene, indicating that the recombination event did occur in or near the
csoS1 insert in pUC18. The sequencing results from the extension of the M13 forward
primer did not show homology to the predicted recombinant construct, suggesting that the
kanamycin construct did not replace the csoS1C gene, rather inserted near the end of the
csoS1 insert. The sequencing of the second plasmid (Figure 24, clone 6) obtained from the
extension of the M13 forward primer revealed homology to the original acceptor plasmid.
The sequence obtained using the M13 reverse primer was homologous to the kanamycin
cassette. Again, the kanamycin cassette did not replace the csoS1C gene, but inserted
toward the end of the csoS1 insert or on the pUC18 plasmid itself. The presence of the
kanamycin cassette in the extension of the M13 reverse primer, suggests that the cassette
was closer to the M13 reverse primer site on the plasmid (Figure 12).
The expected deletion construct was not generated; however, a recombination event
did occur. The linearization of recombinant plasmid DNA (Figure 24) resulted in a 4.3 kb
fragment consistent with the predicted size of the recombinant. However, sequencing
determined that the kanamycin cassette did not replace the csoS1C gene but inserted further
downstream. It is possible that some epigenetic characteristic that prevented the desired
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recombination developed during the generation of the pUC18HnPE2.0 plasmid. Further
research into the recombination event is necessary to determine why the kanamycin
cassette did not replace the csoS1C gene.
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